|
Volumn 43, Issue 2, 2007, Pages 722-726
|
Stability-indicating HPTLC determination of imatinib mesylate in bulk drug and pharmaceutical dosage form
|
Author keywords
Degradation; HPTLC; Imatinib mesylate; Stability indicating; Validation
|
Indexed keywords
IMATINIB;
PROTEIN TYROSINE KINASE INHIBITOR;
ANALYTIC METHOD;
ARTICLE;
CALIBRATION;
CANCER THERAPY;
DRUG CAPSULE;
DRUG DEGRADATION;
DRUG DETERMINATION;
DRUG DOSAGE FORM COMPARISON;
DRUG FORMULATION;
DRUG HYDROLYSIS;
DRUG STABILITY;
HEAT;
HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY;
INSTRUMENTATION;
OXIDATION;
PH;
POWDER;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
STANDARD;
TEMPERATURE;
THERMOSTABILITY;
ANTINEOPLASTIC AGENTS;
CALIBRATION;
CAPSULES;
CHLOROFORM;
CHROMATOGRAPHY, THIN LAYER;
DENSITOMETRY;
DRUG STABILITY;
GUIDELINES;
HYDROLYSIS;
LINEAR MODELS;
METHANOL;
OXIDATION-REDUCTION;
PIPERAZINES;
POWDERS;
PROTEIN KINASE INHIBITORS;
PYRIMIDINES;
QUALITY CONTROL;
REPRODUCIBILITY OF RESULTS;
SENSITIVITY AND SPECIFICITY;
SILICON DIOXIDE;
SOLVENTS;
TECHNOLOGY, PHARMACEUTICAL;
TEMPERATURE;
|
EID: 33845609757
PISSN: 07317085
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jpba.2006.07.022 Document Type: Article |
Times cited : (29)
|
References (14)
|